Anticoagulation in Atrial Fibrillation With Previous Intracranial Bleeding

This publication has 30 references indexed in Scilit:

• Effect of oral anticoagulant therapy on adverse outcomes in patients with atrial fibrillation after intracranial hemorrhage
  Heart Rhythm, 2025
• Direct oral anticoagulants versus no anticoagulation for the prevention of stroke in survivors of intracerebral haemorrhage with atrial fibrillation (PRESTIGE-AF): a multicentre, open-label, randomised, phase 3 trial
  The Lancet, 2025
• Atrial fibrillation: stroke prevention
  The Lancet Regional Health - Europe, 2024
• Effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage (COCROACH): prospective, individual participant data meta-analysis of randomised trials
  The Lancet Neurology, 2023
• Antithrombotic treatment after stroke due to intracerebral haemorrhage
  Cochrane Database of Systematic Reviews, 2023
• Association of Prior Intracerebral Hemorrhage With Major Adverse Cardiovascular Events
  JAMA Network Open, 2022
• The nationwide Finnish anticoagulation in atrial fibrillation (FinACAF): study rationale, design, and patient characteristics
  European Journal of Epidemiology, 2022
• Risks of recurrent stroke and all serious vascular events after spontaneous intracerebral haemorrhage: pooled analyses of two population-based studies
  The Lancet Neurology, 2021
• Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
  The Lancet, 2014
• The feasibility of combining data from routine Hospital Discharge and Causes-of-Death Registers for epidemiological studies on stroke
  European Journal of Epidemiology, 2000